Evidence map›Paper›PMID 36705754›Full record

ArticlePediatric nephrology (Berlin, Germany)2023

Factors affecting dialysis duration in children with Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome.

Myda Khalid, Chloe Miller, Netsanet Gebregziabher, Zoe Guckien, Shrea Goswami, Anthony Perkins, Sharon Phillips Andreoli

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Myda KhalidJames Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA. khalidm@iu.edu.ORCID http://orcid.org/0000-0002-0613-3790
Chloe MillerJames Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA.
Netsanet GebregziabherDepartment of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, USA.
Zoe GuckienJames Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA.
Shrea GoswamiJames Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA.
Anthony PerkinsDepartment of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, USA.
Sharon Phillips AndreoliJames Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA.
Riley Hospital for Children · USIndiana University School of Medicine

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPredicting disease severity can be informative for management of HUS. Dialysis requirement, volume depletion, elevated white blood cell counts, very young age, and use of antimotility agents are known factors associated with severe HUS.

methodsA retrospective cohort analysis was performed to identify factors associated with dialysis duration using electronic medical record and chart review of 76 children ≤ 18 years of age at presentation with STEC-HUS identified through billing data from July 2008 to April 2020 at James Whitcomb Riley Hospital for Children, Indiana University, Indiana.

resultsNovel findings associated with prolonged dialysis duration were age ≥ 6 years old at presentation (p = 0.041) and lack of drop in platelets below 60,000/mm

conclusionsAge ≥ 6, elevated WBC count > 20,000/mm

Indexed as

Escherichia coli InfectionsHemolytic-Uremic SyndromeShiga-Toxigenic Escherichia coliAnti-Inflammatory Agents, Non-SteroidalChildHumansRenal DialysisRetrospective StudiesAnti-Inflammatory Agents, Non-SteroidalChildrenDialysisHematocritHemolytic uremic syndromeNSAIDPlatelet countShiga toxin–producing Escherichia coliSTEC-HUSWhite blood cell count

Identifiers

PMID36705754
OpenAlexW4318219094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.